Koji Todaka

Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial

Kiminori Kimura, Akemi Ikoma, Maki Shibakawa et al. · EBioMedicine · 2017 · 100 citations · Full text

Dynamic effects of carotid sinus baroreflex on ventriculoarterial coupling studied in anesthetized dogs.

Takeshi Kubota, Joe Alexander, Ryoichi Itaya et al. · Circulation Research · 1992 · 53 citations

Dynamic Effects, Anesthetized Dogs, Cardiac Mechanic +14

Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study

Kiminori Kimura, Tatsuya Kanto, Shinji Shimoda et al. · EBioMedicine · 2022 · 49 citations · Full text

Effects of levosimendan on myocardial contractility and oxygen consumption.

Koji Todaka, Jie Wang, Geng‐Hua Yi et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 46 citations

Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting

Susumu Takase, Tetsuya Matoba, Soichi Nakashiro et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2016 · 45 citations · Full text